Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses.

Kirkham BW, Corkill MM, Davison SC, Panayi GS.

J Rheumatol. 1991 Jun;18(6):821-5.

PMID:
1895263
2.

Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapy.

Kirkham BW, Davison SC, Corkill MM, Barbatis C, Panayi GS.

J Rheumatol. 1993 Jun;20(6):935-9.

PMID:
8350327
3.

Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis.

De A, Blotta HM, Mamoni RL, Louzada P, Bertolo MB, Foss NT, Moreira AC, Castro M.

J Rheumatol. 2002 Jan;29(1):46-51.

PMID:
11824970
4.

Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis.

Carpenter AB, Eisenbeis CH Jr, Carrabis S, Brown MC, Ip SH.

J Clin Lab Anal. 1990;4(2):130-4.

PMID:
2313471
5.
7.
8.

Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.

Symons JA, Wood NC, Di Giovine FS, Duff GW.

J Immunol. 1988 Oct 15;141(8):2612-8.

PMID:
3262665
9.

Monocytes are essential for inhibition of synovial T-cell glucocorticoid-mediated apoptosis in rheumatoid arthritis.

Makrygiannakis D, Revu S, Neregård P, af Klint E, Snir O, Grundtman C, Catrina AI.

Arthritis Res Ther. 2008;10(6):R147. doi: 10.1186/ar2582. Epub 2008 Dec 19.

10.

Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid.

Miossec P, Elhamiani M, Edmonds-Alt X, Sany J, Hirn M.

Arthritis Rheum. 1990 Nov;33(11):1688-94.

PMID:
2242065
11.

Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis.

Suenaga Y, Yasuda M, Yamamoto M, Nonaka S, Wada T, Shiokawa S, Nobunaga M.

Clin Rheumatol. 1998;17(4):311-7.

PMID:
9776115
12.

Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.

Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA.

Arthritis Rheum. 1988 Jul;31(7):844-9.

PMID:
3134896
13.

Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.

Merkel PA, Dooley MA, Dawson DV, Pisetsky DS, Polisson RP.

J Rheumatol. 1996 Nov;23(11):1856-61.

PMID:
8923356
14.

[Soluble interleukin 2 receptor (sIL-2R) in chronic polyarthritis].

Herzog C, Herzog A, Aeschlimann A, Gerber H, Müller W.

Z Rheumatol. 1990 Jan-Feb;49(1):8-10. German.

PMID:
2327181
15.
16.

Methotrexate: mechanism of action in rheumatoid arthritis.

Segal R, Yaron M, Tartakovsky B.

Semin Arthritis Rheum. 1990 Dec;20(3):190-200. Review.

PMID:
2287944
17.

Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint.

Symons JA, McDowell TL, di Giovine FS, Wood NC, Capper SJ, Duff GW.

Lymphokine Res. 1989 Fall;8(3):365-72.

PMID:
2789325
18.
19.

Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation.

van Roon J, Wijngaarden S, Lafeber FP, Damen C, van de Winkel J, Bijlsma JW.

J Rheumatol. 2003 Apr;30(4):648-51.

PMID:
12672180
20.

Interleukin-2 secretion by synovial fluid lymphocytes in rheumatoid arthritis.

Ruschen S, Lemm G, Warnatz H.

Br J Rheumatol. 1988 Oct;27(5):350-6.

PMID:
3263162

Supplemental Content

Support Center